HIV-1 and HIV-2 prevalence and associated risk factors among postnatal women in Harare, Zimbabwe

Epidemiology and Infection

Volumn 135, Issue 6, 2007, Pages 933-942

  Humphrey, J H ^a,f   Nathoo, K J ^b   Hargrove, J W ^c   Iliff, P J ^b   Mutasa, K E ^c   Moulton, L H ^a   Chidawanyika, H ^c   Malaba, L C ^b   Zijenah, L S ^b   Zvandasara, P ^b   Ntozini, R ^c   Zunguza, C D ^d   Ward, B J ^e  

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^b UNIVERSITY OF ZIMBABWE   (Zimbabwe)

^c ZVITAMBO Study Team   (Zimbabwe)

^d Harare City Health Department   (Zimbabwe)

^e MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

^f NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HUMAN IMMUNODEFICIENCY VIRUS ANTIBODY;

ADOLESCENT; ADULT; AGE DISTRIBUTION; ARTICLE; CONTROLLED STUDY; EDUCATIONAL STATUS; ENZYME LINKED IMMUNOSORBENT ASSAY; EPIDEMIC; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 2; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION RATE; LOWEST INCOME GROUP; MARRIED WOMAN; MULTIVARIATE ANALYSIS; NONHUMAN; PARITY; PERINATAL PERIOD; PREVALENCE; RELIGION; RISK FACTOR; SOCIAL SUPPORT; SUPERINFECTION; ZIMBABWE; AGE; ISOLATION AND PURIFICATION; PREGNANCY; PUERPERIUM; SOCIOECONOMICS; VIROLOGY;

ADOLESCENT; ADULT; AGE FACTORS; FEMALE; HIV INFECTIONS; HIV-1; HIV-2; HUMANS; MULTIVARIATE ANALYSIS; PARITY; POSTPARTUM PERIOD; PREGNANCY; PREVALENCE; RISK FACTORS; SOCIOECONOMIC FACTORS; ZIMBABWE;

EID: 34748817979     PISSN: 09502688     EISSN: 14694409     Source Type: Journal    
DOI: 10.1017/S0950268806007709     Document Type: Article

References (26)

1. Zaba B, Boerma T, White R. Monitoring the AIDS epidemic using HIV prevalence data among young women attending antenatal clinics: Prospects and problems. AIDS 2000; 14: 1633-1645.
2. WHO. Evaluation of a national AIDS programme. A methods package; 1. Prevention of HIV infection. WHO/GPA/TCO/SEF/94.1.1994. WHO: Geneva.
3. UNAIDS/WHO/MEASURE Evaluation/USAID. National AIDS programmes: A guide for monitoring and evaluation. Draft, 1999. Geneva: UNAIDS/WHO.
4. Mahomed K, et al. Seroprevalence of HIV infection amongst antenatal women in greater Harare, Zimbabwe. Central African Journal of Medicine 1991; 37: 322-325.
5. Mbizvo MT, et al. Trends in HIV-1 and HIV-2 prevalence and risk factors in pregnant women in Harare, Zimbabwe. Central African Journal of Medicine 1996; 42: 14-21.
6. Mahomva AI, et al. HIV prevalence and trends from data in Zimbabwe, 1997-2004. Sexually Transmitted Infection 2006; 82 (Suppl. 1): I42-i47.
7. Malaba LC, et al. Effect of postpartum maternal or neonatal vitamin A supplementation on infant mortality-among infants born to HIV-negative mothers in Zimbabwe. American Journal of Clinical Nutrition 2005; 81: 454-60.
8. Humphrey JH, et al. Effects of a single large dose of vitamin A, given during the postpartum period to HIV-positive women and their infants, on child HIV infection, HIV-free survival, and mortality. Journal of Infectious Diseases 2006; 193: 860-871.
9. Humphrey JH, et al. HIV incidence among postpartum women in Zimbabwe: Risk factors and the effect of vitamin A supplementation. AIDS 2006; 20: 1437-1446.
10. Iliff PJ, et al. Early exclusive breastfeeding reduces the risk of postnatal HIV-1 transmission and increases HIV-free survival. AIDS 2005; 19: 699-708.
11. Reeves JD, Doms RW. Human immunodeficiency virus type 2. Journal of General Virology 2002; 83: 1253-1265.
12. Rodes B, et al. Viral response to antiretroviral therapy in a patient co infected with HIV Type 1 and Type 2. Clinical Infectious Diseases 2005; 41: E19-e21.
13. Graham WJ, Newell M.-L. Seizing the opportunity: Collaborative initiatives to reduce HIV and maternal mortality. Lancet 1999; 353: 836-839.
14. Temmerman M, et al. Infection with HIV as a risk factor for adverse obstetrical outcome. AIDS 1990; 4: 1087-1093.
15. Ministry of Health and Child Welfare. National survey of HIV and syphilis prevalence among women attending antenatal clinics in Zimbabwe, 2002, pp. 1-38, 2002.
16. Gregson S, et al. Study of bias in HIV-1 surveillance data in a high contraceptive prevalence population in sub-Saharan Africa. AIDS 2002; 16: 643-652.
17. Ministry of Health and Child Welfare. Zimbabwe National HIV and AIDS Estimates. Zimbabwe: MOHCW, 2003.
18. UNAIDS. Evidence for HIV decline in Zimbabwe: A comprehensive review of the epidemiological data, pp. 1-45, 20006.
19. Gregson S, et al. HIV decline associated with behaviour change in Eastern Zimbabwe. Science 2006; 311: 664-666.
20. Sarr AD, et al. HIV-1 and HIV-2 dual infection: Lack of HIV-2 provirus correlates with low CD4+ lymphocyte counts. AIDS 1998; 12: 131-137.
21. Duncan ME, et al. First coitus before menarche and risk of sexually transmitted disease. Lancet 1990; 335: 338-340.
22. Pettifor AE, et al. Early age of first sex: A risk factor for HIV infection among women in Zimbabwe. AIDS 2004; 18: 1435-1442.
23. Casella JF. Time from HIV-1 seroconversion to AIDS and death before widespread use of highly-active anti-retroviral therapy. A collaborative analysis. Lancet 2005; 335: 1131-1137.
24. Gregson S, Zaba B, Garnett GP. Low fertility in women with HIV and the impact of the epidemic on orphanhood and early childhood mortafity in sub-saharan Africa. AIDS 1999; 13: S249-S257.
25. Gray RH, et al. Population-based study of fertility in women with HIV-1 infection in Uganda. Lancet 1998; 351: 98-103.
26. Terceira N, et al. The contribution of HIV to fertility decline in rural Zimbabwe, 1980-2000. Population Studies 2003; 57: 149-164.